Rx Rundown: Biogen, Novartis, Arbutus Biopharma and more
Check out this week’s medical marketing news, people on the move and industry chatter.
Source: mmm-online.com
Page 5 - William Collier News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from William Collier. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In William Collier Today - Breaking & Trending Today
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV...
Source: marketscreener.com
Arbutus Biopharma Corp (ABUS) Reports Q3 2023 Financial Results
Company continues clinical trials and reduces workforce by 24% amidst pipeline optimization
Source: yahoo.com
Arbutus Announces CEO, William Collier, to Retire December 31, 2023 - Arbutus Biopharma (NASDAQ:ABUS)
Michael J. McElhaugh, Arbutus Co-founder and COO, to Serve as Interim CEO WARMINSTER, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (NASDAQ:ABUS) ("Arbutus" or the "Company"), a clinical-stage
Source: benzinga.com
Arbutus Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Arbutus Biopharma (NASDAQ:ABUS)
Multiple data presentations upcoming at AASLD – The Liver Meeting®, including preliminary data from Phase 2a clinical trial combining imdusiran, our RNAi therapeutic, with VTP-300, an HBV antigen-specific
Source: benzinga.com